NSE filing, NSE: BALPHARMA. Summary written from the filing by ALFA Finder's alert engine.
Bal Pharma Ltd: key numbers
- Share price
- ₹81.85
- Market cap
- ₹130.3 Cr
- Revenue (annual)
- ₹311.7 Cr
- Net profit (annual)
- ₹6.28 Cr
- P/E (TTM)
- 18.1×Sector 45.9×
- Promoter holding
- 50.86%+0.00% QoQ
- FII holding
- 0.28%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Bal Pharma Ltd
All →Bal Pharma Other Announcement
Bal Pharma Ltd has filed its quarterly shareholding pattern as mandated under Regulation 31(1)(b) of the SEBI Listing Regulations.
Bal Pharma Dividend
Bal Pharma disbursed its FY25-26 final dividend of ₹1.20 per share on October 9, 2026. Dividends for shareholders with incomplete KYC or bank details have been withheld.
Bal Pharma Management Change
Bal Pharma Limited announced a change in designations for directors Ravindra Kumar Kothari and Virupakshaya Himesh, effective October 1, 2026.
Bal Pharma Annual General Meeting
Bal Pharma Ltd held its 39th Annual General Meeting on September 24, 2026, where shareholders transacted all business items as per the notice.
Bal Pharma Price Movement Clarification
Bal Pharma has clarified that the recent significant movement in its share price is purely market-driven and not due to any undisclosed price-sensitive information.
Bal Pharma Other Announcement
Bal Pharma Ltd has filed its quarterly shareholding pattern for the period ended March 31, 2026, in compliance with SEBI regulations.
Other other announcement announcements
All →Juniper Green Energy Other Announcement
Juniper Green Energy filed CARE Ratings' monitoring agency report for the quarter ended September 2026. Report confirms IPO proceeds used as per offer document, with no deviations.
Bright Outdoor Media Other Announcement
Bright Outdoor Media Ltd filed its half-yearly shareholding pattern for the period ended September 30, 2026. This is a routine SEBI Reg 31 holding statement with no transaction or business event.
Munoth Communication Other Announcement
Munoth Communication filed its quarterly shareholding pattern for the quarter ended September 30, 2026. The filing is a routine periodic disclosure with no transaction.
Purple Style Labs Other Announcement
Purple Style Labs Limited (unlisted) filed its quarterly shareholding pattern for the quarter ended 30 September 2026 under Regulation 31(1)(b). It is a routine periodic disclosure with no transaction or money involved.
Chemkart India Other Announcement
Chemkart India reported no IPO fund deviation for the half year ended 30 September 2026. Rs.39.48 Crore of Rs.64.47 Crore allocation is utilised.
Zee Entertainment Enterprises Other Announcement
Zee Entertainment updated its authorised KMP list for Reg 30 disclosures, effective 2 November 2026, after a Company Secretary change. No money or business event is involved.